| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.034 | 0.8 |